(Q36798015)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17449500%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

0 references

1 reference

title

Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17449500%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17449500%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

David J Sheridan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17449500%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Timothy Paterson

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17449500%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

English

0 references

publication date

20 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17449500%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17449500%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17449500%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17449500%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

1433-1440

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17449500%20AND%20SRC:MED&resulttype=core&format=json

Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK.

29 December 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Recent developments in atrial fibrillation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Novel therapeutics for treatment of long-QT syndrome and torsade de pointes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Measuring inconsistency in meta-analyses

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Interaction revisited: the difference between two estimates

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Risk of mortality in a cohort of patients newly diagnosed with chronic atrial fibrillation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Magnesium: physiology and pharmacology

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Magnesium and cardiovascular drugs: interactions and therapeutic role

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Effect of intravenous magnesium sulfate on supraventricular tachycardia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Effect of magnesium sulfate on ventricular rate control in atrial fibrillation.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Effects of magnesium sulfate on cardiac conduction and refractoriness in humans.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Hemodynamic effects of intravenously administered magnesium on patients with ischemic heart disease.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

A randomized controlled trial of magnesium sulfate, in addition to usual care, for rate control in atrial fibrillation.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Adjunctive intravenous magnesium to reduce toxicity and enhance efficacy of class III antiarrhythmic agents.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Cost effectiveness of ibutilide with prophylactic magnesium in the treatment of atrial fibrillation

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Impact of prophylactic i.v. magnesium on the efficacy of ibutilide for conversion of atrial fibrillation or flutter.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Intravenous amiodarone for cardioversion of recent-onset atrial fibrillation.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Antiarrhythmic effect of magnesium sulfate after open heart surgery: effect of blood levels

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Effects of intravenous magnesium sulfate on the QT interval in patients receiving ibutilide

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Effects of MgSO4 and glucose, insulin and potassium (GIK) on atrial conduction during the first 12 hours after DC-conversion of chronic atrial fibrillation

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Magnesium efficacy in magnesium deficient and nondeficient patients with rapid ventricular response atrial fibrillation.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Intravenous magnesium sulfate versus diltiazem in paroxysmal atrial fibrillation

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Intravenous MgSO4 alone and in combination with glucose, insulin and potassium (GIK) prolong the atrial cycle length in chronic atrial fibrillation.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Efficacy of intravenous magnesium sulphate in supraventricular tachyarrhythmias.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Magnesium therapy in new-onset atrial fibrillation

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Parenteral magnesium sulfate versus amiodarone in the therapy of atrial tachyarrhythmias: a prospective, randomized study.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2016911

Effect of intravenous magnesium on heart rate and heart rate variability in patients with chronic atrial fibrillation

4 December 2018

1 reference

12 December 2020

[The effect of intravenous magnesium on the arrhythmias in patients after electrical cardioversion]

1 reference

12 December 2020

1 reference

12 December 2020

A new-onset atrial fibrillation: the incidence of potassium and magnesium deficiency. The efficacy of intravenous potassium/magnesium supplementation in cardioversion to sinus rhythm

1 reference

12 December 2020

Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm

1 reference

12 December 2020

[Value of magnesium chloride in supraventricular paroxysmal tachycardia and tachycardia caused by auricular fibrillation]

1 reference

12 December 2020

Magnesium content of serum, circulating mononuclear cells, skeletal muscle, and myocardium in congestive heart failure

1 reference

12 December 2020

Ionic biology and ionic medicine in cardiac arrhythmias with particular reference to magnesium

1 reference

12 December 2020

The effect of magnesium versus verapamil on supraventricular arrhythmias

1 reference

12 December 2020

[Magnesium protects myocardium during electric cardioversion but does not increase effectiveness]

1 reference

12 December 2020

Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications

1 reference

12 December 2020

Identifiers

DOI

10.1136/HRT.2006.111492

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17449500%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17449500%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

PubMed publication ID

17449500

1 reference